A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses is a research paper published in Advances in Radiation Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5K12CA001727-23
National Cancer Institute
Grant: P30CA033572
NCI NIH HHS
Grant: K12 CA001727
Merck & Co Inc
FWCI
0.49
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals